Nicholas A. Marston, MD, MPH; Robert P. Giugliano, MD, SM; Giorgio E. M. Melloni, PhD; et al.
free access
has audio
JAMA Cardiol. 2022;7(3):250-256. doi:10.1001/jamacardio.2021.5083
This cohort study evaluates whether common measures of cholesterol concentration, triglyceride concentration, or their ratio are associated with cardiovascular risk beyond the number of apolipoprotein B–containing lipoproteins.
-
Podcast:
Highlights From the American Heart Association’s Scientific Sessions 2021
Lili Zhang, MD, ScM; Devvora Olalere, MS; Thomas Mayrhofer, PhD; et al.
free access
JAMA Cardiol. 2022;7(3):259-267. doi:10.1001/jamacardio.2021.5340
This cohort study compares the risk factors and noninvasive testing outcomes of Black and White persons with stable chest pain.
Alisse Hauspurg, MD; Derek J. Marsh, MS; Rebecca B. McNeil, PhD; et al.
free access
JAMA Cardiol. 2022;7(3):268-276. doi:10.1001/jamacardio.2021.5617
This cohort study investigates whether higher concentrations of N-terminal pro–brain natriuretic peptide (NT-proBNP) in early pregnancy are associated with hypertensive disorders of pregnancy and hypertension 2 to 7 years post partum.
Zachary Tran, MD; Roland Hernandez, MD, JD, MPH; Josef Madrigal, BS; et al.
free access
JAMA Cardiol. 2022;7(3):277-285. doi:10.1001/jamacardio.2021.5370
This cohort study evaluates center-level transplant rates following the recent allocation policy change for heart transplant.
Ludwig T. Weckbach, MD; Lisa Schweizer, MSc; Angelina Kraechan, MD; et al.
open access
has active quiz
JAMA Cardiol. 2022;7(3):286-297. doi:10.1001/jamacardio.2021.5133
This case series uses histologic, transcriptomic, and proteomic profiling to investigate the inflammatory cardiac phenotype among patients with SARS-CoV-2 infection compared with patients with noninflammatory cardiomyopathy and virus-associated and immune-mediated myocarditis.
Kate Hanneman, MD, MPH; Christian Houbois, MD; Alice Schoffel, MPH; et al.
free access
JAMA Cardiol. 2022;7(3):298-308. doi:10.1001/jamacardio.2021.5505
This cohort study examines myocardial metabolic changes early after recovery from COVID-19 using fluorodeoxyglucose–positron emission tomography (PET) and shows an association of these changes with abnormalities in cardiac magnetic resonance imaging (MRI)–based function and tissue characterization measures and inflammatory blood markers.
Donghee Han, MD; Andrew Lin, MBBS, PhD; Keiichiro Kuronuma, MD; et al.
free access
has audio
JAMA Cardiol. 2022;7(3):309-319. doi:10.1001/jamacardio.2021.5705
This cohort study assesses the association of adverse geometric characteristics of coronary lesions with location and vessel geometry on coronary computed tomographic angiography.
-
Podcast:
Association of Plaque Location and Vessel Geometry With Future ACS–Causing Culprit Lesions
Matheus Simonato, MD; Ori Ben-Yehuda, MD; Flavien Vincent, MD, PhD; et al.
free access
JAMA Cardiol. 2022;7(3):320-327. doi:10.1001/jamacardio.2021.5724
This systematic review and meta-analysis assesses the impact of imprecise event rate estimations on interpretation of peer-reviewed randomized clinical trials.
-
Invited Commentary
Noninferiority Margins in Clinical Trials—A Moving Target?
Li Wang, PhD, MS, MBA; Rebecca Torguson, MPH; Andrew Farb, MD
JAMA Cardiol
Maryam Esmaeilzadeh, MD; Camila M. Urzua Fresno, MD; Emily Somerset, MSc; et al.
free access
JAMA Cardiol. 2022;7(3):330-340. doi:10.1001/jamacardio.2021.5881
This cohort study evaluates the accuracy of echocardiography and serum biomarkers in diagnosing cancer therapy–related cardiac dysfunction.